Director, Global Medical Oncology, Emerging Assets

Role Summary

The Global Medical Director for Iza-bren serves as the strategic and operational leader for the global medical strategy of the Iza-bren asset, with a focus on key indications under the leadership of the Medical Product Lead. This role shapes the medical vision, drives execution across the asset lifecycle, and ensures alignment with broader Oncology portfolio objectives in a rapidly evolving oncology landscape.

Responsibilities

• Drive the development and execution of the global medical strategy for Iza-bren, ensuring alignment with clinical development, commercial, and access teams.
• Serve as an advisor and collaborator to the MPL to support the Global Product Team (GPT) and cross-functional launch teams.
• Translate clinical development insights into medical plans that support launch readiness and lifecycle management.
• Engage with key external stakeholders including thought leaders, investigators, and advocacy groups to gather insights and foster scientific exchange.
• Represent BMS at global oncology congresses and forums, elevating the visibility of Iza-bren and its clinical value.
• Partner with R&D to influence trial design, endpoints, and data generation strategies for Iza-bren.
• Collaborate with Commercial, Market Access, and HEOR to integrate medical perspectives into brand strategy and patient journey mapping.
• Work closely with Medical Communications teams to ensure scientific alignment and impactful dissemination of data.
• Lead the medical planning process for Iza-bren, including budgeting, resource forecasting, and performance tracking.
• Provide medical review and strategic input for content development, ensuring consistency with asset strategy.
• Facilitate matrix meetings and ensure effective follow-up on decisions, risks, and action items.
• Identify opportunities for innovation in medical execution, including digital engagement and real-world evidence generation.
• Contribute to broader Oncology initiatives such as Project Converge and strategic planning across Thoracic and HN tumors.
• Support business development evaluations and alliance partnerships relevant to Iza-bren.

Qualifications

• Advanced scientific degree (MD, PhD, PharmD) with oncology specialization preferred.
• Minimum 5-7 years of experience in medical affairs or clinical development within the biopharmaceutical industry.
• Proven leadership in global medical strategy and cross-functional team management.
• Strong understanding of oncology therapeutic landscape, particularly thoracic cancers.
• Excellent communication, stakeholder engagement, and strategic planning skills.